10 Results for "

Lck-IN-2

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "Lck-IN-2" in MCE Product Catalog:

Cat. No.: HY-163278
CAS No.: 2615173-24-3
Target:  

Src Apoptosis

Research Areas:  

Cancer

Lck-IN-2 (compound 12a) is an inhibitor of Lymphocyte-specific protein tyrosine kinase (Lck) with IC50 of 10.6 nM. Lck-IN-2 reveals efficacy in colon cancer cells with GI50s of 0.24-1.26 μM. Lck-IN-2 exhibits an apoptotic effect in Colo201 cells .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-12076
CAS No.: 1025720-94-8
Purity:  99.36%
Synonyms: BMS 817378
Target:  

c-Met/HGFR TAM Receptor

Research Areas:  

Cancer

BMS 777607 (BMS 817378) is a Met-related inhibitor for c-Met, Axl, Ron and Tyro3 with IC50s of 3.9 nM, 1.1 nM, 1.8 nM and 4.3 nM, respectively, and 40-fold more selective for Met-related targets than Lck, VEGFR-2, and TrkA/B, with more than 500-fold greater selectivity versus all other receptor and non receptor kinases .
loading...
    loading...
Cat. No.: HY-10644
CAS No.: 944795-06-6
Purity:  99.73%
Target:  

Src Btk Syk

Research Areas:  

Others

Lck inhibitor 2 is a bisanilino pyrimidine-derived tyrosine kinase inhibitor targeting LCK, BTK, LYN, SYK and TXK, with a Kd value of 10 nM against TXK .
loading...
    loading...
Cat. No.: HY-112809
CAS No.: 1398695-47-0
Purity:  98.39%
Research Areas:  

Inflammation/Immunology

GSK2646264 (Compound 44) is a potent and selective spleen tyrosine kinase (SYK) inhibitor with a pIC50 of 7.1. GSK2646264 also inhibits other kinases with pIC50 values of 5.4, 5.4, 5.3, 5, 4.5, <4.6 and <4.3 against LCK, LRRK2, GSK3β, JAK2, VEGFR2, Aurora B and Aurora A, respectively. GSK2646264 is penetrable into the epidermis and dermis of the skin .
loading...
    loading...
Cat. No.: HY-175463
CAS No.: 3095032-50-8
Target:  

Molecular Glues Src

Research Areas:  

Cancer

LCK degrader-2 (Compound 17) is a Lck Molecular glue degrader. LCK degrader-2 can be used for cancers like acute lymphoblastic leukemia (ALL) research .
loading...
    loading...
Cat. No.: HY-P1377A
Target:  

Src

Caffeic acid-pYEEIE TFA, a phosphopeptide inhibitor, exhibits potent binding affinity for the GST-Lck-SH2 domain .
loading...
    loading...
Cat. No.: HY-18307
CAS No.: 913376-84-8
Target:  

c-Met/HGFR

Research Areas:  

Cancer

SYN1143 is a potent, selective and orally active dual inhibitor of c-Met/RON, with IC50s of 4 and 9 nM, respectively. SYN1143 has weak inhibitory activity on Lck, Tie2, Src, and BTK with IC50s ranging from 160 to 710 nM. SYN1143 can be used for the research of cancers that RON and c-Met are activated .
loading...
    loading...
Cat. No.: HY-P1377
CAS No.: 507471-72-9
Target:  

Src

Research Areas:  

Inflammation/Immunology

Caffeic acid-pYEEIE, a phosphopeptide inhibitor, exhibits potent binding affinity for the GST-Lck-SH2 domain .
loading...
    loading...
Cat. No.: HY-10644R
CAS No.: 944795-06-6
Target:  

Reference Standards Src

Research Areas:  

Inflammation/Immunology

Lck inhibitor 2 (Standard) is the analytical standard of Lck inhibitor 2 (HY-10644). This product is intended for research and analytical applications. Lck inhibitor 2 is a multi-target tyrosine kinase inhibitor with IC50s of 13nM, 9nM, 3nM, 26nM and 2nM for Lck, Btk, Lyn, Btk and Txk respectively.
loading...
    loading...
Cat. No.: HY-D3058
CAS No.: 1338346-32-9
FITC-amide-C2 Lck inhibitor 2 is a FITC-labeled Lck inhibitor .
loading...
    loading...